Literature DB >> 26461143

Temperature-sensitive miR-483 is a conserved regulator of recombinant protein and viral vector production in mammalian cells.

Verena V Emmerling1,2, Simon Fischer3, Fabian Stiefel3, Karlheinz Holzmann4, René Handrick3, Friedemann Hesse3, Markus Hörer2,5, Stefan Kochanek1, Kerstin Otte6.   

Abstract

Cell engineering and bioprocess optimizations such as low temperature cultivation represent powerful tools to improve cellular performance and product yields of mammalian production cells. Besides monoclonal antibodies (mABs), novel biotherapeutic formats such as viral vectors will gain increasing importance. Here, we demonstrate that similar to Chinese hamster ovary (CHO) cells, product yields of recombinant adeno-associated virus (rAAV) producing HeLa cells can be markedly increased by low temperature cultivation. MicroRNAs (miRNAs) are small non-coding RNAs that critically regulate cell phenotypes. We thus investigated differential miRNA expression in response to mild hypothermia in CHO and HeLa production cells. We discovered miR-483 to be substantially up-regulated upon temperature down-shift in both cell types. Functional validation experiments revealed that introduction of miR-483 mimics led to a significant increase in both rAAV and mAB production in HeLa and CHO cells, respectively. Furthermore, inhibition of miR-483 up-regulation during mild hypothermia significantly decreased product yields, suggesting that miR-483 is a key regulator of cellular productivity in mammalian cells. In addition, miRNA target gene identification indicated that miR-483 might regulate genes directly involved in cellular survival and protein expression. Our results highlight that miR-483 is a valuable tool for product-independent engineering of mammalian production cells.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Adeno-associated virus; HeLa packaging cells; hypothermia; miR-483; microRNA; viral vector

Mesh:

Substances:

Year:  2015        PMID: 26461143     DOI: 10.1002/bit.25853

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

Review 1.  Recent developments in miRNA based recombinant protein expression in CHO.

Authors:  Masoume Bazaz; Ahmad Adeli; Mohammad Azizi; Masoud Soleimani; Fereidoun Mahboudi; Noushin Davoudi
Journal:  Biotechnol Lett       Date:  2022-05-04       Impact factor: 2.461

Review 2.  Methods for Using Small Non-Coding RNAs to Improve Recombinant Protein Expression in Mammalian Cells.

Authors:  Sarah Inwood; Michael J Betenbaugh; Joseph Shiloach
Journal:  Genes (Basel)       Date:  2018-01-09       Impact factor: 4.096

3.  Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy.

Authors:  Rachael A Potter; Danielle A Griffin; Patricia C Sondergaard; Ryan W Johnson; Eric R Pozsgai; Kristin N Heller; Ellyn L Peterson; Kimmo K Lehtimäki; Hillarie P Windish; Plavi J Mittal; Douglas E Albrecht; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  Hum Gene Ther       Date:  2017-07-13       Impact factor: 5.695

4.  miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development.

Authors:  Simon Fischer; Kim F Marquart; Lisa A Pieper; Juergen Fieder; Martin Gamer; Ingo Gorr; Patrick Schulz; Harald Bradl
Journal:  Biotechnol Bioeng       Date:  2017-04-18       Impact factor: 4.530

Review 5.  The Effect of microRNA on the Production of Recombinant Protein in CHO Cells and its Mechanism.

Authors:  Hui-Ning Liu; Wei-Hua Dong; Yan Lin; Zhao-Hui Zhang; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-03-21

Review 6.  The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer.

Authors:  Felice Pepe; Rosa Visone; Angelo Veronese
Journal:  Cancers (Basel)       Date:  2018-06-04       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.